These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10339661)

  • 1. Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells.
    Matsubara H; Kimura M; Sugaya M; Koide Y; Gunji Y; Takegana K; Asano T; Ochiai T; Isono K; Sakiyama S; Tagawa M
    Int J Oncol; 1999 Jun; 14(6):1081-5. PubMed ID: 10339661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.
    Maeda T; Matsubara H; Koide Y; Sugaya M; Miyazawa Y; Tasaki K; Isono K; Ochiai T; Sakiyama S; Tagawa M
    Anticancer Res; 2000; 20(2A):869-74. PubMed ID: 10810368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and genetic characterization of a non-metastatic human esophageal cancer cell line, T.Tn expressing non-functional mutated p53.
    Sakai T; Furihata T; Kawamata H; Omotehara F; Shinagawa Y; Imura J; Kubota K; Terano A; Fujimori T
    Int J Oncol; 2002 Sep; 21(3):547-52. PubMed ID: 12168098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
    Nabeya Y; Loganzo F; Maslak P; Lai L; de Oliveira AR; Schwartz GK; Blundell ML; Altorki NK; Kelsen DP; Albino AP
    Int J Cancer; 1995 Feb; 64(1):37-46. PubMed ID: 7665247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells.
    Matsubara H; Maeda T; Gunji Y; Koide Y; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Int J Oncol; 2001 Apr; 18(4):825-9. PubMed ID: 11251180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antitumor effect on human esophageal carcinoma cells by the retroviral expression of granulocyte macrophage-colony stimulating factor gene.
    Sugaya M; Tagawa M; Matsubara H; Gunji Y; Takenaga K; Maeda T; Koide Y; Asano T; Ochiai T; Isono K; Sakiyama S
    Int J Oncol; 1998 Feb; 12(2):321-4. PubMed ID: 9458356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
    He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
    Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity.
    Cheng TC; Hsieh SS; Hsu WL; Chen YF; Ho HH; Sheu LF
    Int J Oncol; 2010 Jan; 36(1):151-60. PubMed ID: 19956844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of wild-type p53 gene transfection on the growth and cisplatin sensitivity of cervical cancer cell line HeLa].
    Wang X; Peng Z; Wang H
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):40-2. PubMed ID: 12599424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The protocol of clinical trial and basic experiments for esophageal cancer using gene transduction].
    Matsubara H; Ochiai T
    Nihon Rinsho; 2000 Sep; 58(9):1935-43. PubMed ID: 11004829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression.
    Yang S; Kawamura K; Okamoto S; Yamauchi S; Shingyoji M; Sekine I; Kobayashi H; Tada Y; Tatsumi K; Hiroshima K; Shimada H; Tagawa M
    BMC Cancer; 2015 Jun; 15():464. PubMed ID: 26059686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53.
    Gjerset RA; Turla ST; Sobol RE; Scalise JJ; Mercola D; Collins H; Hopkins PJ
    Mol Carcinog; 1995 Dec; 14(4):275-85. PubMed ID: 8519417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
    Wang S; El-Deiry WS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.
    Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T
    Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition.
    Matsubara H; Koide Y; Sugaya M; Gunji Y; Asano T; Ochiai T; Takegana K; Sakiyama S; Tagawa M
    Int J Oncol; 1998 Dec; 13(6):1217-22. PubMed ID: 9824634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene reflects the status of p53 gene in human esophageal cancer cells.
    Matsubara H; Kawamura K; Sugaya M; Koide Y; Gunji Y; Takenaga K; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Anticancer Res; 1999; 19(5B):4157-60. PubMed ID: 10628368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.